Adjuvants in vaccines are chemicals, microbial components, or mammalian proteins that boost the immune response to vaccine antigens. The aim to limit vaccine-related side effects while also inducing specific types of immunity has resulted in the development of various new adjuvants. Adjuvant technologies used in veterinary vaccination are more diverse, including aluminum salts, oil-in-water, water-in-oil, or multiple emulsions, polymer dispersions, saponins, and certain other naturally occurring immunostimulants. Some of the leading players in the Asia Pacific, Europe & North America veterinary vaccine adjuvants market offer the most recent vaccination adjuvants and contribute to market growth. For instance, Seppic develops and markets a variety of vaccination adjuvant technologies for human and animal health, particularly the Montanide line of oily and polymeric adjuvants. Strategic initiatives by market participants is estimated to showcase substantial growth prospects for Asia Pacific, Europe & North America veterinary vaccine adjuvants market, over the period of next eight years. Croda International Plc., for instance, announced the acquisition of Avanti Polar Lipids in July 2020. Through the combined range of capabilities and expertise, the companies aim to expand their respective range of products and services, so as to establish a stronger hold in the overall market, while also strengthening their offerings to varied end use sectors including pharmaceutical companies, biotechnology businesses and academic institutions.

Access the Full Report @

Increase in research and development for discovering new vaccines along with growing demand for advanced treatment options for animals in North America is expected to drive the growth of the veterinary vaccine adjuvants market in this region. Europe accounted for the second largest share in the Asia Pacific, Europe & North America veterinary vaccine adjuvants market. Increasing technological advancement and growing emphasis for existing and emerging zoonotic diseases is expected to contribute to the growth of the market in the Europe region. Also, Favourable government regulation regarding the development of vaccines in the major economies such as Germany, the UK, Italy, etc. is a major reason for the significant share of Europe in the veterinary vaccine adjuvants market.

In terms of revenue, global veterinary vaccine adjuvants market was valued at US$ 326.33 Mn in 2020 growing at a CAGR of 5.9% over the forecast period (2021 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Asia Pacific, Europe & North America Veterinary Vaccine Adjuvants Market:

By Adjuvant Type:

  • Aluminum Salts
  • Oil Emulsion (Oil in Water, Water in Oil, Etc.)
  • Polymer Dispersions
  • Saponins
  • Others

By Route of Administration:

  • Oral
  • Injectable
  • Mucosal
  • Others

By Animal Type

  • Poultry
  • Fishes
  • Swine
  • Cattle and Small Ruminants
  • Pets and Horses
  • Others

By End Use

  • Commercial Manufacturing
  • Research

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Contact Us:
Company: Absolute Markets Insights
Email Id:
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna